Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.

The pathological basis of dementia and visual hallucinations in Parkinson's disease (PD) is not yet fully understood. To investigate this further we have conducted a clinico-pathological study based on 30 post-mortem PD brains. PD cases were stratified into groups according to clinical characteristics as follows: (1) cognitively intact (n=9); (2) cases with severe dementia and visual hallucinations (n=12); (3) cases with severe dementia and no visual hallucinations (n=4); and (4) cases with severe visual hallucinations and no dementia (n=5). The extent of alpha-synuclein (alphaSyn), tau and amyloid beta peptide (Abeta) deposition was then examined in the CA2 sector of the hippocampus and in neocortical and subcortical areas known to subserve cognitive function. We find that dementia in PD is significantly associated with alphaSyn in the anterior cingulate gyrus, superior frontal gyrus, temporal cortex, entorhinal cortex, amygdaloid complex and CA2 sector of the hippocampus. Abeta in the anterior cingulate gyrus, entorhinal cortex, amygdaloid complex and nucleus basalis of Meynert is also associated with dementia as is tau in the CA2 sector of the hippocampus. alphaSyn burden in the amygdala is strongly related to the presence of visual hallucinations but only in those PD cases with concomitant dementia. Statistical analysis revealed that alphaSyn burden in the anterior cingulate gyrus could differentiate demented from non-demented PD cases with high sensitivity and specificity. We conclude that alphaSyn in limbic regions is related to dementia in PD as well as to visual hallucinations when there is an underlying dementia.

[1]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[2]  M. Graeber,et al.  Comparative study of commercially available anti‐α‐synuclein antibodies , 2006, Neuropathology and applied neurobiology.

[3]  이필휴 A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007 .

[4]  W. Poewe Psychosis in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[5]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[6]  J. Cummings,et al.  Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.

[7]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[8]  A. Parent Extrinsic connections of the basal ganglia , 1990, Trends in Neurosciences.

[9]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[10]  C. Marsden,et al.  HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.

[11]  M. Botvinick,et al.  Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Mrc Psych,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .

[13]  D. Dickson,et al.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease , 2000, Acta Neuropathologica.

[14]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[15]  M. Serby,et al.  Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. , 1978, The American journal of psychiatry.

[16]  J. Cummings,et al.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.

[17]  R E Harlan,et al.  The accumbens: beyond the core-shell dichotomy. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[18]  J. Troncoso,et al.  Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. , 2005, Neurobiology of aging.

[19]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[20]  A. David,et al.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.

[21]  P. Lantos,et al.  Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease , 1996, Neuroscience Letters.

[22]  D. Dickson,et al.  Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease , 1998, Acta Neuropathologica.

[23]  L. Hazrati,et al.  Functional anatomy of the basal ganglia , 1995 .

[24]  H. Klawans,et al.  Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.

[25]  David R Williams,et al.  Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.

[26]  Joon-Kee Yoon,et al.  A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007, European journal of neurology.

[27]  M. Graeber,et al.  Striatal &bgr;-Amyloid Deposition in Parkinson Disease With Dementia , 2008, Journal of neuropathology and experimental neurology.

[28]  S. Papapetropoulos,et al.  Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease? , 2005, Acta neurologica Scandinavica.

[29]  Deborah C Mash,et al.  Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. , 2006, Parkinsonism & related disorders.

[30]  C. Shepherd,et al.  Relationship between neuronal loss and ‘inflammatory plaques’ in early onset Alzheimer's disease , 2007, Neuropathology and applied neurobiology.

[31]  M. MacDonald,et al.  An Improved Approach to Prepare Human Brains for Research , 1995, Journal of neuropathology and experimental neurology.

[32]  M. Barcikowska,et al.  Dementia in Parkinson's disease. , 1994, Dementia.

[33]  D. Aarsland,et al.  Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study , 2005, Annals of neurology.

[34]  G. Wooten,et al.  Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[35]  C. Goetz,et al.  Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.

[36]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[37]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[38]  Lipton Ra,et al.  Letter: Factor VIII. , 1973, Lancet.

[39]  K. Jellinger Striatal beta-amyloid deposition in Parkinson disease with dementia. , 2008, Journal of neuropathology and experimental neurology.

[40]  J. Cummings,et al.  Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[41]  G. Stebbins,et al.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.

[42]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[43]  R. Grünewald,et al.  Hallucinosis in idiopathic Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[44]  Glenda M. Halliday,et al.  Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.

[45]  P. Hof,et al.  Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.

[46]  B. Vogt,et al.  Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.

[47]  J. Rinne,et al.  Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology , 1999, Acta Neuropathologica.

[48]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[49]  Y. Agid,et al.  Confusion, dementia and anticholinergics in Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. Sanchez-Ramos,et al.  Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.

[51]  J. Troncoso,et al.  Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases , 2005, Neurobiology of Aging.

[52]  A. Lees,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.

[53]  I. Ferrer,et al.  Assessment of &agr;-Synuclein Pathology: A Study of the BrainNet Europe Consortium , 2008, Journal of neuropathology and experimental neurology.

[54]  S. J. Newman,et al.  A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. , 1997, Neuroreport.

[55]  R. Harper,et al.  Coloured Lilliputian Hallucinations with Amantadine , 1973, The Medical journal of Australia.

[56]  I. Ferrer,et al.  Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.

[57]  A. Lees,et al.  The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease , 1997, Neurology.

[58]  J. Feigenson,et al.  Piribedil: Its synergistic effect in multidrug regimens for parkinsonism , 1976, Neurology.

[59]  J. Cummings Behavioral Complications of Drug Treatment of Parkinson's Disease , 1991, Journal of the American Geriatrics Society.

[60]  A. Dale,et al.  Dorsal anterior cingulate cortex: A role in reward-based decision making , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[62]  T. Paus Primate anterior cingulate cortex: Where motor control, drive and cognition interface , 2001, Nature Reviews Neuroscience.

[63]  A. Lees,et al.  Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients , 2008, Acta Neuropathologica.

[64]  H. Braak,et al.  Pattern of brain destruction in Parkinson's and Alzheimer's diseases , 2005, Journal of Neural Transmission.

[65]  D. Mash,et al.  Dementia in Parkinson's disease: a post‐mortem study in a population of brain donors , 2005, International journal of geriatric psychiatry.

[66]  Dc Washington Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .